Hodgkin's Lymphoma in Children and Adolescents: A Study from Saint Petersburg
Author Information
Author(s): Svetlana A. Kulyova, Boris A. Kolygin
Primary Institution: N.N. Petrov Research Institute of Oncology
Hypothesis
The study aims to analyze the efficacy of the SPbHL-05 protocol for treating Hodgkin's lymphoma in children and adolescents.
Conclusion
The study suggests that using risk-adapted treatment strategies can improve outcomes for children with Hodgkin's lymphoma while reducing treatment-related toxicity.
Supporting Evidence
- The overall survival rate at 5 years was 91.3%.
- Event-free survival was 82.8% after treatment.
- No patients developed second malignancies during the study.
Takeaway
This study looked at how to treat kids with Hodgkin's lymphoma better, finding that some treatments work really well and have fewer side effects.
Methodology
The study involved 60 patients under 18 years old treated with a risk-adapted chemotherapy protocol followed by radiotherapy.
Limitations
The follow-up period was limited to a median of 68 months, which may not capture long-term outcomes.
Participant Demographics
{"male_female_ratio":"1:1.3","median_age":14,"age_distribution":{"less_than_9_years":10,"10_years_or_older":90},"stage_distribution":{"stage_I":5,"stage_II":48.3,"stage_III":21.7,"stage_IV":25},"b_symptoms":{"present":38.3,"absent":61.7},"histology":{"lymphocyte_predominance":3.3,"nodular_sclerosis":76.7,"mixed_cellularity":15,"not_subclassified":5},"bulky_disease":{"absent":45,"present":55}}
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website